A biosensor based on Zn(II) metal–organic framework NPs can detect the PSA at a detection limit of 0.145 fg/mL where the PSA concentration > 10 ng/mL is considered a threat for suspected prostate cancers [206]. This evidence concerns the gene KLK3 and prostate carcinoma.